SteriGenics Acquires RTI
TM Capital assisted SteriGenics International, Inc. (NASDAQ) in acquiring the business and assets of RTI, Inc.
TM Capital assisted SteriGenics International, Inc. (NASDAQ) in acquiring the business and assets of RTI, Inc.
TM Capital advised Surpass Medical, Ltd. in its sale to Stryker Corporation (NYSE:SYK) for $135 million in cash and future consideration
TM Capital advised the Board of Directors of Immucor, Inc.(NASDAQ) in connection with a proxy contest in which all of Immucor’s directors were successfully re-elected
TM Capital served as exclusive financial advisor to Quantib B.V., a portfolio company of Holland Capital, in connection with its sale to RadNet, Inc.